Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant hepatic arterial infusion pump chemotherapy after repeat hepatectomy for recurrent colorectal liver metastases
2019-003966-42Phase 2Active
- Sponsor
- Erasmus MC
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of floxuridine in colorectal cancer (CRC), sponsored by Erasmus MC. Started Feb 2021; status: active.
02
Drugs
floxuridine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2019-003966-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003966-42.